Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
Take a baby with RSV to the hospital or call 911 right away if they show signs of breathing trouble: pauses in breathing (apnea), very fast or labored breathing, grunting, nostrils flaring, skin pulling in around the ribs or neck, or bluish or gray lips, tongue, or skin. Other urgent warning signs include a fever of 100.4°F or higher in an infant under 3 months, dehydration (far fewer wet diapers, no tears, dry mouth, sunken soft spot), refusing to feed, unusual sleepiness, limpness, or irritability that cannot be soothed. Premature infants, babies under 6 months, and those with heart, lung, or immune conditions face higher risk and may need care sooner, so there are several important factors to consider before waiting it out. See the complete answer below for the full list of red flags, age-specific guidance, and what to expect during hospital treatment.
Because RSV can worsen quickly between days 3 and 5 of illness, it helps to know whether your baby's symptoms point to something that can be managed at home or needs immediate attention. A free, instant, online symptom check can help you organize what you are seeing, understand possible causes, and decide on next steps with more confidence.
Last reviewed for medical accuracy: 09/23/2025
Respiratory syncytial virus (RSV) is a common viral infection in infants and young children. Most cases are mild and can be managed at home. However, RSV can sometimes lead to serious breathing problems, dehydration or other complications that require hospital care. Knowing when to take a baby with RSV to the hospital can help you get prompt treatment and peace of mind.
RSV is a virus that infects the respiratory tract. It spreads easily through coughs, sneezes and close contact. In babies, RSV typically causes:
Symptoms usually start 4–6 days after exposure and peak around days 3–5. In most healthy infants, RSV clears up on its own within 1–2 weeks.
Some babies face a greater chance of severe RSV. You should have a lower threshold for seeking hospital care if your child:
If your baby falls into one of these categories, call your pediatrician early for advice.
Even otherwise healthy infants can develop complications. You should consider going to the emergency department or calling 911 if you notice any of the following:
Signs that your baby isn’t getting enough fluids:
If you’re ever unsure when to take a baby with RSV to the hospital, err on the side of caution. Prompt medical attention can prevent complications.
If you decide to go or are advised to come in, consider these steps:
Having a plan helps reduce stress when your baby needs urgent care.
If your baby has mild symptoms and you’re not sure when to take a baby with RSV to the hospital, try these measures first:
Stay in close contact with your pediatrician and watch for any warning signs.
If you need more specific guidance on your baby’s symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide whether you should head to the hospital or continue home care.
Knowing when to take a baby with RSV to the hospital can be stressful but could make all the difference. Trust your instincts—if something feels seriously wrong, act quickly. Always:
Speak to a doctor about anything that could be life threatening or serious. Prompt evaluation and treatment ensure the best outcome for your little one.
(References)
* Assad Z, Romain AS, Aupiais C, Shum M, Schrimpf C, Lorrot M, Corvol H, Prevost B, Ferrandiz C, Giolito A, Valtuille Z, Bendavid M, Cohen JF, Toubiana J, de Pontual L, Delande CF, Levy M, See P, Cohen R, Levy C, Angoulvant F, Lenglart L, Gits-Muselli M, Biran V, Diallo K, Alemede O, El Hebil MM, Durrmeyer X, Labouret G, Casanovas N, Hallak B, Maréchal O, Jung C, Bréhin C, Ouldali N. Nirsevimab and Hospitalization for RSV Bronchiolitis. N Engl J Med. 2024 Jul 11;391(2):144-154. doi: 10.1056/NEJMoa2314885. PMID: 38986058.
* Branche AR, Saiman L, Walsh EE, Falsey AR, Sieling WD, Greendyke W, Peterson DR, Vargas CY, Phillips M, Finelli L. Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017-2020. Clin Infect Dis. 2022 Mar 23;74(6):1004-1011. doi: 10.1093/cid/ciab595. PMID: 34244735.
* Drysdale SB, Cathie K, Flamein F, Knuf M, Collins AM, Hill HC, Kaiser F, Cohen R, Pinquier D, Felter CT, Vassilouthis NC, Jin J, Bangert M, Mari K, Nteene R, Wague S, Roberts M, Tissières P, Royal S, Faust SN, HARMONIE Study Group. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. N Engl J Med. 2023 Dec 28;389(26):2425-2435. doi: 10.1056/NEJMoa2309189. PMID: 38157500.
* Surie D, Self WH, Yuengling KA, Lauring AS, Zhu Y, Safdar B, Ginde AA, Simon SJ, Peltan ID, Brown SM, Gaglani M, Ghamande S, Columbus C, Mohr NM, Gibbs KW, Hager DN, Prekker M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Gordon AJ, Qadir N, Chang SY, Mallow C, Felzer JR, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Papalambros L, Mosier JM, Harris ES, Baughman A, Cornelison SA, Blair PW, Johnson CA, Lewis NM, Ellington S, Grijalva CG, Talbot HK, Casey JD, Halasa N, Chappell JD, Rutkowski RE, Ma KC, Dawood FS, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network. RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28;334(16):1442-1451. doi: 10.1001/jama.2025.15896. PMID: 40884491; PMCID: PMC12398767.
* Payne AB, Watts JA, Mitchell PK, Dascomb K, Irving SA, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Natarajan K, Sheffield T, Bride D, Arndorfer J, Naleway AL, Koppolu P, Fireman B, Zerbo O, Timbol J, Goddard K, Dixon BE, Fadel WF, Rogerson C, Allen KS, Rao S, Mayer D, Barron M, Reese SE, Rowley EAK, Najdowski M, Ciesla AA, Mak J, Reeves EL, Akinsete OO, McEvoy CE, Essien IJ, Tenforde MW, Fleming-Dutra KE, Link-Gelles R. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. Lancet. 2024 Oct 19;404(10462):1547-1559. doi: 10.1016/S0140-6736(24)01738-0. PMID: 39426837; PMCID: PMC13286031.
* Curns AT, Rha B, Lively JY, Sahni LC, Englund JA, Weinberg GA, Halasa NB, Staat MA, Selvarangan R, Michaels M, Moline H, Zhou Y, Perez A, Rohlfs C, Hickey R, Lacombe K, McHenry R, Whitaker B, Schuster J, Pulido CG, Strelitz B, Quigley C, Dnp GW, Avadhanula V, Harrison CJ, Stewart LS, Schlaudecker E, Szilagyi PG, Klein EJ, Boom J, Williams JV, Langley G, Gerber SI, Hall AJ, McMorrow ML. Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020. Pediatrics. 2024 Mar 1;153(3):e2023062574. doi: 10.1542/peds.2023-062574. PMID: 38298053.
* Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009 Feb 5;360(6):588-98. doi: 10.1056/NEJMoa0804877. PMID: 19196675; PMCID: PMC4829966.
* Tartof SY, Aliabadi N, Goodwin G, Slezak J, Hong V, Ackerson B, Liu Q, Shaw S, Welsh S, Stern JA, Kapadia B, Spence BC, Lewnard JA, Davis GS, Aragones M, Dutro M, Chilson E, Gonzalez E, Hubler R, Chia B, Jodar L, Gessner BD, Begier E. Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease. JAMA Netw Open. 2024 Dec 2;7(12):e2450832. doi: 10.1001/jamanetworkopen.2024.50832. Epub 2024 Dec 2. PMID: 39671195; PMCID: PMC11645642.
* Havers FP, Whitaker M, Melgar M, Pham H, Chai SJ, Austin E, Meek J, Openo KP, Ryan PA, Brown C, Como-Sabetti K, Sosin DM, Barney G, Tesini BL, Sutton M, Talbot HK, Chatelain R, Daily Kirley P, Armistead I, Yousey-Hindes K, Monroe ML, Tellez Nunez V, Lynfield R, Esquibel CL, Engesser K, Popham K, Novak A, Schaffner W, Markus TM, Swain A, Patton ME, Kim L. Burden of Respiratory Syncytial Virus-Associated Hospitalizations in US Adults, October 2016 to September 2023. JAMA Netw Open. 2024 Nov 4;7(11):e2444756. doi: 10.1001/jamanetworkopen.2024.44756. Epub 2024 Nov 4. PMID: 39535791; PMCID: PMC11561688.
* Goldstein LA, Michaels MG, Salthouse A, Toepfer AP, Musa S, Hickey RW, Johnson M, Wang-Erickson AF, Weinberg GA, Szilagyi PG, Schlaudecker EP, Staat MA, Sahni LC, Boom JA, Klein EJ, Englund JA, Schuster JE, Selvarangan R, Harrison CJ, Halasa NB, Stewart LS, Dawood FS, Moline HL, Williams JV. Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 1;156(3). doi: 10.1542/peds.2024-070218. PMID: 40763933; PMCID: PMC12824835.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.